Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation-Reference-Cited by-同舟云学术

Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation

Published:2019-02-05 Issue:1 Volume:9 Page:173-182
ISSN:1877-7171
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:JPD

Author:

Regidor Ignacio¹,Santos-García Diego²,Catalán Mar;ıa José³,Puente Vıctor⁴,Valldeoriola Francesc⁵,Grandas Francisco⁶,Mir Pablo⁷⁸,Parra Juan Carlos⁹,Arbelo José Matías¹⁰

Affiliation:

1. Functional Neurosurgery Unit, Hospital Universitario Ramón y Cajal, Madrid, Spain

2. Department of Internal Medicine, Neurology Section, Hospital Arquitecto Marcide, Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain

3. Department of Neurology, Movement Disorders Unit, Hospital Clínico San Carlos, Madrid, Spain

4. Department of Neurology, Movement Disorders Unit, Parc de salut Mar, Institut Hospital del Mar d’investigacions Mèdicas, Universitat Autònoma de Barcelona, Barcelona, Spain

5. Department of Neurology, Movement Disorders Unit, Hospital Clínic, Barcelona, Spain

6. Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

7. Department of Neurology, Movement Disorders Unit, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain

8. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain

9. AbbVie Spain S.L.U., Madrid, Spain

10. Department of Neurology, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Reference30 articles.

1. Parkinson’s disease: The non-motor issues;Chaudhuri;Parkinsonism Relat Disord,2011

2. Advanced Parkinson’s disease: Clinical characteristics and treatment. Part II;Kulisevsky;Neurologia,2013

3. Milestones in Parkinson’s disease therapeutics;Rascol;Mov Disord,2011

4. Using liquid levodopa in the treatment of Parkinson’s disease. A practical guide;Kurth;Drugs Aging,1997

5. Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson’s disease on individual drug combinations;Nyholm;Clin Neuropharmacol,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease;Neuropsychiatric Disease and Treatment;2023-09

2. Correlations between Nutritional Status and Quality of Life of People with Parkinson’s Disease;Nutrients;2023-07-24

3. Az intestinalis gél bevezetésekor rögzített jellemzők tízéves változásai előrehaladott Parkinson-kóros betegekben;Orvosi Hetilap;2022-07-24

4. Döntési szempontok és az eszközös terápia elfogadásához szükséges idő előrehaladott Parkinson-kórban;Orvosi Hetilap;2021-05-23

5. Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review;Movement Disorders;2021-04-25